Pieris Pharmaceuticals (PIRS)
(Delayed Data from NSDQ)
$11.72 USD
+0.12 (1.03%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $11.78 +0.06 (0.51%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -4.00 |
Last EPS Surprise | 58.33% |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | NA |
Next Year | -56.80 |
EPS (TTM) | -23.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 1.94M | 20.06M | 42.81M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | -56.80 |
# of Estimates | NA | NA | NA | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | NA | NA | NA | -56.80 |
Low Estimate | NA | NA | NA | -56.80 |
Year ago EPS | -14.40 | 4.00 | -9.60 | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | NA | 0 |
Up Last 30 Days | NA | NA | NA | 0 |
Up Last 60 Days | NA | NA | NA | 0 |
Down Last 7 Days | NA | NA | NA | 0 |
Down Last 30 Days | NA | NA | NA | 0 |
Down Last 60 Days | NA | NA | NA | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | NA | -56.80 |
7 Days Ago | NA | NA | NA | -56.80 |
30 Days Ago | -4.80 | -2.40 | -16.00 | -40.00 |
60 Days Ago | -4.80 | -2.40 | -16.00 | -40.00 |
90 Days Ago | -4.80 | -2.40 | -16.00 | -40.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | NA | -56.80 |
Zacks Consensus Estimate | NA | NA | NA | -56.80 |
Earnings ESP | NA | NA | NA | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -4.00 | -8.80 | 4.00 | -14.40 | NA |
Estimate | -9.60 | -8.80 | -12.80 | -11.20 | NA |
Difference | 5.60 | 0.00 | 16.80 | -3.20 | 4.80 |
Surprise | 58.33% | 0.00% | 131.25% | -28.57% | 40.25% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more